Breast and Gynecological Cancer - Insights
Learn how our gynecological cancer and breast cancer treatment tests are designed to provide a detailed picture of a patient’s cancer diagnosis.
Mitochondrial disease - Insights
Learn about our four molecular testing options, which can be used to confirm a diagnosis and identify a specific mitochondrial syndrome.
Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.
Elevating accuracy of Alzheimer's testing - Insights
Learn how Mayo Clinic Laboratories Alzheimer’s disease testing provides clearer answers for more patients by offering the highest level of overall accuracy for the detection of amyloid pathology.
Beyond the test result Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’
Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon,...
Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D. - Insights
Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating...
Autoimmune profile updates - Insights
Based on studies that have shown certain antibodies may not be as clinically relevant to autoimmune testing as previously thought, Mayo Clinic Laboratories is updating a number of its autoimmune profiles by removing some antibodies from...
The Value Stream of an Outreach Program - Insights
When considering the outreach laboratory value stream, it is important to remember that without quality, there is no value. Through identifying sources for error or non-value-added activities, the hospital laboratory outreach program can...
Mass spectrometry-based assay detects viral antigens directly from clinical specimens - Insights
In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity...
Rare Lyme disease-causing bacteria spotted on routine blood films - Insights
It’s been understood for some time that an infection of B. mayonii, a rare species of bacterium, results in high levels of spirochetes in the peripheral blood. But actually being able to visualize them on a routine peripheral blood smear...
New tests launched in February - Insights
In February 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Testing Archives - Page 23 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 7 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
As a global reference laboratory integrated with a world-renowned academic health care institution, Mayo Clinic Laboratories helps providers advance patient care, strengthen your practice, and broaden access to specialized testing. Follow...
Week in Review: April 15 - Insights
Today's highlights include: Facing 'alarming' health care worker shortage, unusual cases of hepatitis in young children, and why women's risk of heart disease increased during the pandemic.
Testing Archives - Page 10 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 22 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 12 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 19 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 18 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
numares and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that will measure clusters of risk factors as opposed to individual biomarkers. The unique testing will use nuclear magnetic resonance...
Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the...
New tests launched in February - Insights
In February 2023, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Laboratory/Patient Safety/Quality Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Lab Medicine Rounds - Insights
A Mayo Clinic podcast for physicians, laboratory professionals, and students hosted by Justin Kreuter, M.D., (the Bow Tie Bandit of Blood) and featuring trending topics from subject-matter experts. Note: Podcasts will not play back on...
Laboratory/Patient Safety - Insights
The following on demand education is related to Laboratory/Patient Safety, which is a key subfield within the medical laboratory science (MLS), that focuses on maintaining a safe environment for both laboratory personnel and patients.
Operational updates - Insights
The latest operational updates from Mayo Clinic Laboratories, including holiday shipping schedules, information technology changes, and more.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory - Insights
A Mayo Clinic podcast for administrators, outreach managers, and laboratory professionals hosted by Jane Hermansen, outreach manager at Mayo Clinic Laboratories, on how to best leverage and optimize the laboratory for patients, clients, and...
Leveraging Lessons from the Past - Insights
Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.
Present Approaches to Testing - Insights
Discussing current test applications that you can implement in your laboratory or practice today.
What the Patient Considers When Choosing a Laboratory - Insights
Patients want to use a laboratory that is easy to work with, and there are different definitions of “easy.” Ultimately, health systems want to have the patients they serve use their health system laboratories. If patients are choosing to go...
Is the term "outreach" obsolete? - Insights
In a competitive outpatient testing market, choosing a laboratory is discretionary. With the goal of becoming the laboratory of choice for discretionary outpatient testing, it no longer matters if it is called “inreach” or “outreach.” While...
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Three core elements of exceptional customer service - Insights
Excellent customer service flows from three foundational elements: organizational alignment, engaged employees, and the right systems and facilities.
Managing Compliance in Preparation for 2025 Updates - Insights
With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans.
Managing off-site phlebotomy: Considerations, coordination, and convenience - Insights
As the phlebotomist ventures farther from the hospital or formal outpatient setting, there are many new facets to consider. Remote phlebotomy is a patient-focused activity and can be a successful attribute for an outreach program when...
Creative approaches to laboratory outreach staffing - Insights
In a constrained staffing environment, how can an outreach program effectively meet customer needs? Through creativity, collaboration, and shared services, there can be multiple solutions to provide the support needed by the laboratory...
Due to a pending winter storm affecting the FedEx hub in Memphis, Tennessee, and the UPS hub in Louisville, Kentucky, Mayo Clinic Laboratories will monitor and track the situation with our logistics partners to minimize challenges. Read...
Monitoring Hurricane Milton - Insights
Hurricane Milton is approaching the west coast of Florida and is anticipated to make landfall Wednesday. We continue to monitor and track the situation with our logistics partners to minimize challenges.
Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D. - Insights
John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent.
Whole genome sequencing streamlines diagnosis - Insights
Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC, explain how Mayo Clinic Laboratories' whole genome sequencing provides comprehensive information for rapid diagnosis of hereditary disorders.